before couple of years, the united kingdom has witnessed a revolution in professional medical bodyweight‑loss treatment plans — through the introduction of semaglutide (Wegovy®) to the growing attractiveness of tirzepatide (Mounjaro®). Now, An additional title is drawing focus in the two medical